Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
Laurence Harris
Advertisement
Laurence Harris is an associate research fellow, analytical research and development, pharmatherapeutics pharmaceutical sciences, Pfizer, Inc.
Articles by Laurence Harris
Advertisement
Latest Updated Articles
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and OpportunitiesPublished: March 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines
2
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
3
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
4
CPHI Frankfurt 2025: The Current API Market
5
